The Juvenescence business model and future of anti-aging

Phil Newman

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Greg Bailey

CEO, Juvenescence

The Juvenescence business model and future of anti-aging

Phil Newman

Editor-in-Chief

Phil is Editor-in-Chief Longevity.Technology and founder of First Longevity which brings together international investors and Longevity start-ups.

In his career, Phil has held c-level management positions; applying his marketing and business development expertise into these tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Genentech pays $100m upfront for Alector’s AL050

Tiny Health lands $33m to read the gut for life

The case for regeneration over slowing decline

Longevity investors put evidence to the test

Brain health ‘collaboratory’ focuses on non-invasive Alzheimer’s therapy

Perplexity enters the consumer health AI arena

Startup targets ‘untreatable blindness’ with bionic eye system

Science Corp lands $230m to commercialize vision restoration chip

MUSCLE: FLT’s revolutionary AI-powered supplement for strength and longevity

The Juvenescence business model and future of anti-aging

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Greg Bailey

CEO, Juvenescence

The Juvenescence business model and future of anti-aging

You might also like

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Tiny Health lands $33m to read the gut for life

The case for regeneration over slowing decline

Longevity investors put evidence to the test

Perplexity enters the consumer health AI arena

Startup targets ‘untreatable blindness’ with bionic eye system

Science Corp lands $230m to commercialize vision restoration chip

Ergothioneine: The little-known molecule transforming brain health and longevity

COGNITION: FLT’s new brain-boosting supplement that’s redefining mental performance

7 Best l-glutamine supplements to buy in 2024

New blue zone found in Sardinian village with no gym

NUS takes longevity science into the boardroom

‘Show me the error bars before you sell me longevity’

The Juvenescence business model and future of anti-aging

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Greg Bailey

CEO, Juvenescence

The Juvenescence business model and future of anti-aging

You might also like

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE